Isoflucypram Patent Landscape Analysis

Isoflucypram is a cereal fungicide developed by Bayer, commercialised through the Iblon® brand and products such as Vimoy®.

The retained landscape covers 49 patent families across 11 consolidated owner groups. Two-active combination is the thickest protection layer (28 families), with manufacturing route and formulation claims providing additional constraint.

45 of the 49 retained families carry a grant or national pending reading. 8 families are held by China-based applicants. 7 live families have a nominal term ending within five years. Position as at November 2026.

This 43-page report provides a seven-part analysis covering ownership, active-ingredient manufacture, single-active formulation, fixed-dose mixtures, national market entry and owner profiles, with route-level remaining-space notes and an appendix owner directory.

Not a freedom-to-operate opinion.